Processing

Please wait...

Settings

Settings

Goto Application

1. WO2019003163 - TERPENE-ENRICHED CANNABINOID PRODUCT FOR WOMEN HEALTH

Publication Number WO/2019/003163
Publication Date 03.01.2019
International Application No. PCT/IB2018/054783
International Filing Date 27.06.2018
IPC
A61K 31/01 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
01Hydrocarbons
A61K 31/352 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 47/10 2017.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
08containing oxygen
10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols ; Poloxamers; PEG/POE alkyl ethers
A61K 47/38 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
47Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
38Cellulose; Derivatives thereof
CPC
A61K 31/01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
01Hydrocarbons
A61K 31/015
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
01Hydrocarbons
015carbocyclic
A61K 31/045
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
A61K 31/05
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
05Phenols
A61K 31/352
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 36/185
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
Applicants
  • BUZZELET DEVELOPMENT AND TECHNOLOGIES LTD. [IL]/[IL]
Inventors
  • RAZ, Noa
  • EYAL, Aharon M.
Agents
  • DIAMANT, Barbara
Priority Data
62/525,83528.06.2017US
62/588,39419.11.2017US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) TERPENE-ENRICHED CANNABINOID PRODUCT FOR WOMEN HEALTH
(FR) PRODUIT CANNABINOÏDE ENRICHI EN TERPÈNE BON POUR LA SANTÉ DES FEMMES
Abstract
(EN)
A product for treating conditions and/or symptoms associated with women health is described, which product comprises at least one cannabinoid in a specific amount, a primary terpene in a specific amount, at least 5% by weight of a non-cannabinoid, non-terpene, carrier, optionally at least three secondary terpenes, and optionally at least one phytoestrogen; wherein said non-cannabinoid, non-terpene carrier comprises cellulose and the terpenes to cannabinoids weight/weight ratio in said product is about 0.1 to about 1.0. Also described is the above product wherein said non-cannabinoid, non-terpene carrier comprises less than 5% by weight cellulose and the terpenes to cannabinoids weight/weight ratio in said compositions is about 0.05 to about 1.0, forming a terpene-enriched product with an enhanced therapeutic effect in treating conditions and/ or symptoms associated with perimenopause, menopause, female urogenital or reproductive system infections and/or disorders, menstrual cycle, hormonal deficiency and/or hormonal imbalance, compared with that of a product comprising the same cannabinoids amounts and one half the amount of said primary terpene.
(FR)
L'invention concerne un produit visant à traiter des affections et/ou des symptômes associés à la santé des femmes, lequel produit comprend une quantité spécifique d'au moins un cannabinoïde, une quantité spécifique d'un terpène primaire, au moins 5 % en poids d'un excipient qui n'est ni un cannabinoïde, ni un terpène, éventuellement au moins trois terpènes secondaires et, éventuellement, au moins un phytoestrogène. Ledit excipient qui n'est ni un cannabinoïde, ni un terpène comprend de la cellulose et le rapport pondéral entre les terpènes et les cannabinoïdes dans ledit produit varie d'environ 0,1 à environ 1,0. L'invention concerne également le produit ci-dessus dans lequel ledit excipient qui n'est ni un cannabinoïde, ni un terpène comprend moins de 5 % en poids de cellulose et le rapport pondéral entre les terpènes et les cannabinoïdes dans lesdites compositions varie d'environ 0,05 à environ 1,0, ce qui donne un produit enrichi en terpènes présentant un effet thérapeutique amélioré dans le traitement d'affections et/ou de symptômes associés à la périménopause, à la ménopause, aux infections et/ou aux troubles du système urogénital ou reproducteur féminin, au cycle menstruel, à l'insuffisance hormonale et/ou au déséquilibre hormonal, par rapport à celui d'un produit comprenant les mêmes quantités de cannabinoïdes et moitié moins dudit terpène primaire.
Latest bibliographic data on file with the International Bureau